NDC 0143-9433-01 - Acetylcysteine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9433
- Requested NDC
- 0143-9433-01
- Package NDCs from labels
- 0143-9433-01, 0143-9433-04
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | ONESOURCE SPECIALTY PHARMA LIMITED
- Effective date
- 2025-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acetylcysteine - Hikma Pharmaceuticals USA Inc. | ONESOURCE SPECIALTY PHARMA LIMITED | Hikma Pharmaceuticals USA Inc. | ONESOURCE SPECIALTY PHARMA LIMITED | 2025-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9433-01 | Acetylcysteine | 30 mL in 1 VIAL | INJECTION, SOLUTION | 30 | 1 | |
| 0143-9433-04 | Acetylcysteine | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9433-01 | ML - Milliliter | 0143-9433 | 4025225a-b7ed-4873-a0cd-91301bcaee7c | 1 | 2026-04-20 |
| 0143-9433-04 | ML - Milliliter | 0143-9433 | e58fe1da-c605-4e0f-954a-62dbcf75ae06 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Folcyteine | MULTIVITAMIN | PureTek Corporation | 04cf0026-e29b-ffd5-e063-6294a90aca1f | 2026-07-08 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Hospira, Inc. | 5558a5f5-e821-473b-7d8a-5d33d09f0586 | 2026-05-22 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Glenmark Pharmaceuticals Inc., USA | f811ddfc-d7c1-4637-ae81-80c38a77cb80 | 2026-05-06 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | d50c8ab6-26f8-4669-89d1-c4d26698159a | 2026-04-11 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Cardinal Health 107, LLC | c90fca12-12fb-4cf6-bd6f-83bc0d95df81 | 2026-04-07 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Eugia US LLC | 5ae53725-1abb-4122-9c85-f26c2c31566c | 2025-12-02 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Sagent Pharmaceuticals | c206c659-16ea-444a-8c60-8a3343400ada | 2025-10-26 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | ONESOURCE SPECIALTY PHARMA LIMITED | 3b0310d2-4e70-4b94-8d69-cb5999a32b54 | 2025-09-12 | Warnings, Adverse reactions | ANDA217182 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Hikma Pharmaceuticals USA Inc. | 277963a0-8ab2-4305-a688-28e47e87c584 | 2025-09-09 | Warnings, Adverse reactions | ANDA217182 0143-9433-04 0143-9433-01 0143-9433 00143943301 465377 9480cdc0-fbc4-411d-b0e8-3d7cf9e9ec7a 277963a0-8ab2-4305-a688-28e47e87c584 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Cameron Pharmaceuticals | 8165ad85-98e7-438f-9567-5cfda88d0ebf | 2025-08-26 | Warnings, Adverse reactions | WYQ7N0BPYC |
| acetylcysteine | ACETYLCYSTEINE | Padagis US LLC | 9d305722-e74f-4f48-8d2c-0daa99144749 | 2025-07-31 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| ACETADOTE | ACETYLCYSTEINE | Cumberland Pharmaceuticals Inc. | 472f158a-5ab9-4308-8e49-1116e6ea3d39 | 2025-04-30 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | American Regent, Inc. | f56b4087-db48-4fd7-84ec-9c927962b805 | 2024-12-17 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 75b48fab-cef6-465c-a1e0-d085b3988bc4 | 2024-08-15 | Warnings, Adverse reactions | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Somerset Therapeutics, LLC | b8d3ed96-d7ee-43f4-986c-a7d04808711a | 2024-06-13 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| ANTI AGE STRESS | ACETYLCYSTEINE - BALLOTA FOETIDA - EPINEPHRINE - GLUTATHIONE - INTERFERON GAMMA-1B - LENOGRASTIM - LITHIUM CARBONATE - MELATONIN - PENICILLIUM GLABRUM - POTASSIUM CARBONATE - PUMMELO - RHODOTORULA RUBRA - SILVER NITRATE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA CEREBRAL CORTEX - SUS SCROFA STOMACH - SUS SCROFA SUPERIOR GASTRIC PLEXUS - SUS SCROFA THALAMUS - | Guna spa | ce25f3c5-20c9-4ba8-ac58-546febf142ec | 2023-11-02 | Warnings | WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Xellia Pharmaceuticals USA LLC | 3e2e187e-2445-43b1-b66c-b828e2adf022 | 2023-05-31 | Warnings, Adverse reactions | ANDA217182 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8cca4e4c-85a2-d575-e053-2995a90a6599 | 2022-10-31 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | d990ef51-ced2-4359-b99b-092334d2dc9b | 2022-10-31 | Warnings, Adverse reactions | 465377 WYQ7N0BPYC |
| Acetylcysteine | ACETYLCYSTEINE | Fresenius Kabi USA, LLC | 8d81039e-20ef-5144-e053-2a95a90a89fd | 2022-10-31 | Warnings, Adverse reactions | WYQ7N0BPYC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.